Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
28.16
+0.14 (0.50%)
Sep 18, 2024, 4:00 PM EDT - Market closed

Company Description

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally.

It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.

It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products.

The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands.

It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies.

The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013.

Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Perrigo Company plc
Perrigo Company logo
Country Ireland
Founded 1887
IPO Date Dec 16, 1991
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 9,140
CEO Patrick Lockwood-Taylor

Contact Details

Address:
The Sharp Building, Hogan Place
Dublin, D02 TY74
Ireland
Phone 353 1 709 4000
Website perrigo.com

Stock Details

Ticker Symbol PRGO
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001585364
CUSIP Number G97822103
ISIN Number IE00BGH1M568
SIC Code 2834

Key Executives

Name Position
Kyle L. Hanson Special Counsel to the Chief Executive Officer and the Board and Interim General Counsel for Strategic Litigation
Patrick Lockwood-Taylor President, Chief Executive Officer and Director
Eduardo Guarita Bezerra Executive Vice President and Chief Financial Officer
Ronald C. Janish Chief Transformation Officer and Executive Vice President of Global Operations and Supply Chain
Svend Andersen Advisor
Shannon Hukill Senior Director of Technical Operations
Alison Ives Executive Vice President and Chief Scientific Officer
Bradley Joseph Vice President of Global Investor Relations and Corporate Communications
Charles Atkinson Executive Vice President, General Counsel and Secretary
Mary Reilly-Brest Director of Global Organizational and Human Resource Development

Latest SEC Filings

Date Type Title
Sep 17, 2024 8-K Current Report
Sep 13, 2024 424B5 Filing
Sep 13, 2024 144 Filing
Sep 12, 2024 FWP Free Writing Prospectus
Sep 9, 2024 424B5 Filing
Sep 9, 2024 S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
Aug 26, 2024 144 Filing
Aug 20, 2024 144 Filing
Aug 9, 2024 8-K Current Report
Aug 7, 2024 144 Filing